Key Visual

Our Services & Products


  • EGFR Liquid was submitted for PMDA approval
    10 October 2019
    On July 10, 2019, Ryo Matoba, the president of DNA Chip Research Inc., announced that they have developed a high-sensitivity genetic test to detect a very small amount of abnormal (mutated) DNAs in blood for targeted therapies of lung cancer, and submitted its program, “EGFR Liquid” Gene Analysis Software for approval from Japanese authorities as a medical program. The genetic test can be used as companion diagnostic test in clinical practice after approval.
    Read more
  • Discontinuation of Hyb-teacher® educational DNA chip kit sales
    June 2019
    Read more